Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care

被引:27
作者
Gordon, AC
Oakervee, HE
Kaya, B
Thomas, JM
Barnett, MJ
Rohatiner, AZS
Lister, TA
Cavenagh, JD
Hinds, CJ
机构
[1] St Bartholomews Hosp, Dept Anaesthesia & Intens Care, London EC1A 7BE, England
[2] St Bartholomews Hosp, Dept Haematol, London EC1A 7BE, England
[3] St Bartholomews Hosp, Dept Informat Serv, London EC1A 7BE, England
[4] St Bartholomews Hosp, Barts & London Queen Marys Sch Med & Dent, Dept Med Oncol, Canc Res UK Med Oncol Unit, London EC1A 7BE, England
关键词
D O I
10.1111/j.1365-2044.2005.04139.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
To determine the incidence and outcome of critical illness amongst the total population of hospital patients with haematological malignancy (including patients treated on the ward as well as those admitted to the intensive care unit), consecutive patients with haematological malignancy were prospectively studied. One hundred and one of the 1437 haemato-oncology admissions (7%) in 2001 were complicated by critical illness (26% of all new referrals). Fifty-four (53%) of these critically ill patients survived to leave hospital and 33 (34%) were still alive after 6 months. The majority (77/101) were not admitted to the intensive care unit but were managed on the ward, often with the assistance of the intensive care team. Independent risk factors for dying in hospital included hepatic failure (odds ratio 5.3, 95% confidence intervals 1.3-21.2) and central nervous system failure (odds ratio 14.5, 95% confidence intervals 1.7-120.5). No patient with four or more organ failures or a Simplified Acute Physiology Score II >= 65 survived to leave hospital. There was close agreement between actual and predicted mortality with increasing Simplified Acute Physiology Score II for all patients, including those not admitted to intensive care.
引用
收藏
页码:340 / 347
页数:8
相关论文
共 23 条
  • [1] [Anonymous], 2000, COMPR CRIT CAR REV A
  • [2] *AUD COMM, 1999, CRIT SUCC PLAC EFF E
  • [3] Simplified acute physiology score II for measuring severity of illness in intermediate care units
    Auriant, I
    Vinatier, I
    Thaler, F
    Tourneur, M
    Loirat, P
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (08) : 1368 - 1371
  • [4] Changing use of intensive care for hematological patients: the example of multiple myeloma
    Azoulay, E
    Recher, C
    Alberti, C
    Soufir, L
    Leleu, G
    Le Gall, JR
    Fermand, JP
    Schlemmer, B
    [J]. INTENSIVE CARE MEDICINE, 1999, 25 (12) : 1395 - 1401
  • [5] PRELIMINARY-OBSERVATIONS ON THE NEUROMUSCULAR ABNORMALITIES IN PATIENTS WITH ORGAN FAILURE AND SEPSIS
    COAKLEY, JH
    NAGENDRAN, K
    HONAVAR, M
    HINDS, CJ
    [J]. INTENSIVE CARE MEDICINE, 1993, 19 (06) : 323 - 328
  • [6] Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients
    Darmon, M
    Azoulay, E
    Alberti, C
    Fieux, F
    Moureau, D
    Le Gall, JR
    Schlemmer, B
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (12) : 1775 - 1780
  • [7] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    Dellinger, RP
    Carlet, JM
    Masur, H
    Gerlach, H
    Calandra, T
    Cohen, J
    Gea-Banacloche, J
    Keh, D
    Marshall, JC
    Parker, MM
    Ramsay, G
    Zimmerman, JL
    Vincent, JL
    Levy, MM
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (03) : 858 - 873
  • [8] EFFICACY OF INTENSIVE-CARE FOR BONE-MARROW TRANSPLANT PATIENTS WITH RESPIRATORY-FAILURE
    DENARDO, SJ
    OYE, RK
    BELLAMY, PE
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (01) : 4 - 6
  • [9] Epner DE, 1996, J INVEST MED, V44, P254
  • [10] THE CASE-CONTROL STUDY - A PRACTICAL REVIEW FOR THE CLINICIAN
    HAYDEN, GF
    KRAMER, MS
    HORWITZ, RI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (03): : 326 - 331